IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 221 filers reported holding IMMUNOGEN INC in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,839,804 | +67.9% | 1,628,217 | +99.6% | 0.07% | +79.5% |
| Q2 2023 | $15,389,183 | +142.2% | 815,537 | -50.7% | 0.04% | +116.7% |
| Q1 2023 | $6,352,904 | -35.2% | 1,654,402 | -16.3% | 0.02% | -41.9% |
| Q4 2022 | $9,806,550 | -15.4% | 1,977,127 | -18.5% | 0.03% | -20.5% |
| Q3 2022 | $11,590,000 | +27.2% | 2,424,757 | +19.7% | 0.04% | +30.0% |
| Q2 2022 | $9,115,000 | -8.2% | 2,025,627 | -2.9% | 0.03% | +3.4% |
| Q1 2022 | $9,929,000 | -47.7% | 2,085,832 | -18.5% | 0.03% | -29.3% |
| Q4 2021 | $19,001,000 | +62.2% | 2,560,774 | +23.9% | 0.04% | +57.7% |
| Q3 2021 | $11,718,000 | -38.0% | 2,066,666 | -27.9% | 0.03% | -39.5% |
| Q2 2021 | $18,892,000 | -8.9% | 2,866,742 | +12.0% | 0.04% | -20.4% |
| Q1 2021 | $20,741,000 | +58.3% | 2,560,629 | +26.1% | 0.05% | +42.1% |
| Q4 2020 | $13,099,000 | +121.9% | 2,030,870 | +23.9% | 0.04% | +81.0% |
| Q3 2020 | $5,902,000 | +18.2% | 1,639,442 | +51.0% | 0.02% | -16.0% |
| Q2 2020 | $4,994,000 | +32.1% | 1,085,653 | -2.1% | 0.02% | -19.4% |
| Q1 2020 | $3,781,000 | -25.6% | 1,108,810 | +11.4% | 0.03% | +106.7% |
| Q4 2019 | $5,083,000 | +1079.4% | 995,634 | +458.6% | 0.02% | +1400.0% |
| Q3 2019 | $431,000 | -67.3% | 178,251 | -70.6% | 0.00% | -75.0% |
| Q2 2019 | $1,317,000 | -21.0% | 606,929 | -1.3% | 0.00% | -20.0% |
| Q1 2019 | $1,667,000 | -68.6% | 614,980 | -44.4% | 0.01% | -76.2% |
| Q4 2018 | $5,313,000 | +1343.8% | 1,106,879 | +2747.6% | 0.02% | +2000.0% |
| Q3 2018 | $368,000 | -84.3% | 38,871 | -82.6% | 0.00% | -87.5% |
| Q1 2018 | $2,348,000 | -64.1% | 223,216 | -78.1% | 0.01% | -61.9% |
| Q4 2017 | $6,539,000 | +125.2% | 1,020,089 | +168.9% | 0.02% | +110.0% |
| Q3 2017 | $2,903,000 | +741.4% | 379,420 | +682.8% | 0.01% | +900.0% |
| Q2 2017 | $345,000 | -51.3% | 48,467 | -86.0% | 0.00% | -66.7% |
| Q4 2016 | $708,000 | -25.3% | 347,034 | -1.9% | 0.00% | 0.0% |
| Q3 2016 | $948,000 | -68.3% | 353,576 | -63.6% | 0.00% | -76.9% |
| Q2 2016 | $2,990,000 | +831.5% | 970,895 | +2803.1% | 0.01% | +550.0% |
| Q3 2015 | $321,000 | +116.9% | 33,443 | +224.7% | 0.00% | +100.0% |
| Q2 2015 | $148,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |